Related references
Note: Only part of the references are listed.Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts
Stefan J. Cano et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Revising the definition of Alzheimer's disease: a new lexicon
Bruno Dubois et al.
LANCET NEUROLOGY (2010)
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Harald Hampel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
The Coalition Against Major Diseases: Developing Tools for an Integrated Drug Development Process for Alzheimer's and Parkinson's Diseases
K. Romero et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Donepezil treatment of patients with MCI A 48-week randomized, placebo-controlled trial
R. S. Doody et al.
NEUROLOGY (2009)
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease - A randomized controlled trial
Paul S. Aisen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
A neuropsychological test battery for use in Alzheimer disease clinical trials
John Harrison et al.
ARCHIVES OF NEUROLOGY (2007)
Mini-mental State Examination performance in mild cognitive impairment subtypes
Breno S. O. Diniz et al.
INTERNATIONAL PSYCHOGERIATRICS (2007)
Clinical trials in mild cognitive impairment: lessons for the future
V Jelic et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Vitamin E and donepezil for the treatment of mild cognitive impairment
RC Petersen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment
LJ Thal et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Share Paper
